Transitional cell carcinoma natural history, complications and prognosis

Revision as of 15:09, 30 August 2015 by Jyostna Chouturi (talk | contribs)
Jump to navigation Jump to search

Transitional cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Transitional cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Cystoscopy and Bladder Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Transitional cell carcinoma natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Transitional cell carcinoma natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Transitional cell carcinoma natural history, complications and prognosis

CDC on Transitional cell carcinoma natural history, complications and prognosis

Transitional cell carcinoma natural history, complications and prognosis in the news

Blogs on Transitional cell carcinoma natural history, complications and prognosis

Directions to Hospitals Treating Transitional cell carcinoma

Risk calculators and risk factors for Transitional cell carcinoma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Natural History

Complications

Bladder cancers may spread into the nearby organs. They may also travel through the pelvic lymph nodes and spread to the liver, lungs, and bones. Additional complications of bladder cancer include:

Prognosis

How well a patient with bladder cancer does depends on the initial stage and response to treatment of the bladder cancer.

The outlook for stage 0 or I cancers is fairly good. Although the risk of the cancer returning is high, most bladder cancers that return can be surgically removed and cured. After treatment for bladder cancer, patient should be closely monitored for return of cancer. This may include:

  • Bone scans and CT scans to check for the spread or return of cancer
  • Monitoring symptoms that might suggest the disease is getting worse, such as fatigue, weight loss, increased pain, decreased bowel and bladder function, and weakness
  • Complete blood count (CBC) to monitor for anemia
  • Bladder exams every 3 to 6 months after treatment
  • Urinalysis if you did not have your bladder removed

The cure rates for people with stage III tumors are less than 50%. Patients with stage IV bladder cancer are rarely cured.

References

Template:WH Template:WS